The Middle East and Africa Diabetes Market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly soon. This chronic disease can lead to severe medical conditions such as stroke, heart attack or kidney failure. From last two decades, the prevalence of diabetes has increased rapidly in Middle East and Africa region and about 10% of the population is suffering from diabetes. Due to lack of body activity or exercise and eating unhealthy and junk food are leading the growth for the market. In countries like Saudi Arabia, Kuwait, Bahrain, Qatar, and UAE, about 24%, 23%, 22%, 20% and 19% of population is affected by this disease respectively. These countries are among the countries with the highest prevalence of this disease.

Middle East and Africa Diabetes Market trends Size was valued at USD 1.1 Billion in 2022. The Middle East and Africa Diabetes market industry is projected to grow from USD 1.17 Billion in 2023 to USD 2.005 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.90% during the forecast period (2023 - 2032). 

Middle East and Africa Diabetes Market Players:

There are plenty of large and small market players which operate in Middle East and Africa diabetes market are: Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), Sanofi-Aventis U.S. LLC (US), Ypsomed (Switzerland)

Regional Analysis:

Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is believed to be the largest market for diabetes. Moreover, the UAE is also growing and is the second largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is expected to grow at significant rate in the Middle East and Africa diabetes market during the forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate growth in the market.

Segmentation:

Middle East and Africa Diabetes Market Insights has been segmented based on type which comprise Type 1, Type 2, and Gestational diabetes.

Based on test, market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others.

Based on devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others.

Based on treatment market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com